Extended Data Table 1 Association of participant characteristics and CHF incidence further adjusted for weight reduction

From: Effectiveness of bariatric metabolic surgery versus glucagon-like peptide-1 receptor agonists for prevention of congestive heart failure

  1. 1- Diabetes duration- the number of years elapsed form the time of diagnosis with diabetes until the index date, defined as a first BMS or the initiation of treatment with GLP1-RA; 2- Maximal weight reduction (%)- calculated as the percent change of BMI from baseline to the lowest value achieved during follow-up.
Back to article page